Original news and analysis on international IP policy
United States Senate Judiciary Committee Chairman Charles Grassley, an Iowa Republican, has demanded answers from the government Medicare programme regarding the rapid rise in costs of coverage of Americans’ prescription drugs. The demand follows a press report showing an extremely…
Google is doing more to counter online copyright infringement than ever before, it said in its “How Google Fights Piracy 2016 Update,” claiming takedowns of over 500 million webpages in response to rights holder requests. Yet the music industry and an academic said the company needs to up its game.
From Infojustice.org: Letter from 56 Non-profit Organizations and Academic Experts to Secretary Kerry Regarding State Department Pressure Against Access to Medicines Efforts
Pulse Electronics was guilty of patent infringement. That had been decided long ago. The only remaining issue was how much Pulse must pay for its wrongdoing. The company could be liable for treble damages, provided its infringement was willful. Fortunately for Pulse, willful infringement was almost impossible to prove, thanks to a standard established by the Federal Circuit. Unfortunately for Pulse, its lawsuit reached the US Supreme Court. And in its recent ruling on the case, the high court threw out the Federal Circuit’s standard, making it far easier to prove willful infringement. The decision is likely to have an important impact on patent litigation, the courts, and companies doing business in the US.
New documents reveal that the oil and tobacco industries took pages from the same book to engineer their decade long campaigns on denying the existence of climate change and smoking-related cancer. The playbook also appears to have originated not with tobacco, but with the oil industry itself, and the two even appeared to share patents.
Blockstream, which developed the blockchain technology and bitcoin, has announced a defensive patent strategy. The crux of it: assurance that users of its technology won't be sued.
A Wells Fargo bank manager in California worked with two colleagues to conduct a scam targeting trademark holders and launder the proceeds, the United States Department of Justice said today.
Top negotiators of the European Union and United States today underlined after the 14th round of negotiations for the Transatlantic Trade and Investment Partnership (TTIP) that they are still on track for finalising the deal during the outgoing Obama administration. At the same time, they acknowledged that after three years of negotiations some chapters have never been discussed.
Worldwide sales for orphan drugs are forecast to reach $178 billion by 2020, according to a recent industry report. Moreover, the orphan drug market is expected to grow almost 12 percent per year, a level the broader pharmaceutical market “could only dream about” with its expected annual growth of 5.9 percent, according to Lisa Urquhart, editor of EvaluatePharma Vantage.
Gilead is the US company whose use of patents to charge $1000 per pill for a hepatitis C medicine in the United States helped make high drug prices a developed country household issue and fodder for elected officials seeking change. Now the company has come under further fire after being found to have moved some US$10 billion overseas to avoid US taxes - even after having received US taxpayer support for its activities - which it orchestrated by moving its patent rights overseas. A new report detailing the company's tax dodge includes a proposal for a way to clamp down on this type of patent activity.
BARCELONA, Spain -- A recent industry conference panel here covered topics of changing intellectual property scenarios perceived from different angles, in particular from operating companies which manufacture products or services and patent assertion entities (PAEs).
Populism is in vogue these days and critics of pharmaceutical patents are trying to ride the wave, claiming that undermining patents will dramatically decrease prices but not reduce innovation. Both sides of that claim are flawed, writes Steven Tepp.